|
 
 |
| LETTER TO EDITOR |
|
| Year : 2020 | Volume
: 15
| Issue : 2 | Page : 333 |
|
Thrombocytopenia among patients with novel wuhan coronavirus infection: An observation on 42 cases in the 1st month of outbreak
Sora Yasri1, Viroj Wiwanitkit2
1 KMT Primary Care Center, Bangkok, Thailand
2 Dr. DY Patil University, Pune, Maharashtra, India; Hainan Medical University, Haikou, China
| Date of Submission | 28-Jan-2020 |
| Date of Decision | 18-Feb-2020 |
| Date of Acceptance | 30-Mar-2020 |
| Date of Web Publication | 21-Dec-2020 |
Correspondence Address:
Dr. Sora Yasri
KMT Primary Care Center, Bangkok
Thailand
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jdmimsu.jdmimsu_27_20
How to cite this article:
Yasri S, Wiwanitkit V. Thrombocytopenia among patients with novel wuhan coronavirus infection: An observation on 42 cases in the 1st month of outbreak. J Datta Meghe Inst Med Sci Univ 2020;15:333 |
How to cite this URL:
Yasri S, Wiwanitkit V. Thrombocytopenia among patients with novel wuhan coronavirus infection: An observation on 42 cases in the 1st month of outbreak. J Datta Meghe Inst Med Sci Univ [serial online] 2020 [cited 2021 Jan 20];15:333. Available from: http://www.journaldmims.com/text.asp?2020/15/2/333/304255 |
Dear Editor,
In December 2019, a new emerging infectious disease, Wuhan novel coronavirus infection, was reported from China.[1] The patients usually have fever and pneumonia.[1] At present, this emerging disease already exists outside China, and the infection is presently a new public health concern worldwide.[2] Regarding the new coronavirus infection, an important consideration in clinical hematology is the hematological alteration due to infection. In Middle East respiratory syndrome (MERS), a recent emerging coronavirus infection, thrombocytopenia is a common clinical finding.[3] Here, the authors assessed on the available data on 42 infected cases during the 1st month of outbreak, in China and Thailand,[1],[2] to find out the magnitude of thrombocytopenia. Of interest, no patient has presented with thrombocytopenia. Unlike MERS, the novel Wuhan coronavirus infection has no clinical association with thrombocytopenia.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
| References | |  |
| 1. | Hsia W. Emerging new coronavirus infection in Wuhan, China: Situation in early 2020. Case Study Case Rep 2020;10:8-9.  |
| 2. | Yasri S, Wiwanitkit V. Editorial: Wuhan coronavirus outbreak and imported case. Adv Trop Med Pub Health Int 2019;9:1-2. |
| 3. | Joob B, Wiwanitkit V. Magnitude to thrombocytopenia among the patients with novel Middle East respiratory syndrome. Platelets 2015;26:612. |
|
Search Pubmed for